FDA Device Establishments · JSON-LD · Markdown

SHIRE HUMAN GENETIC THERAPIES, INC.

FEI 3009340644 · Develop Specifications But Do Not Manufacture At This Facility · Status: Active

FEI Number3009340644
Owner / OperatorTakeda Pharmaceuticals U.S.A., Inc. (#10051446)
Address300 SHIRE WAY, Lexington, MA, US
Registration expiry2026
Initial importer flagY
Registered products1
Product codes (top 20)LHI
Regulation § (21 CFR)880.5440
Proprietary namesBaxject II Needleless Transfer Device

External sources

Source: openFDA. Public-domain (CC0).